Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012 - PubMed (original) (raw)
Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012
Howard W Rogers et al. JAMA Dermatol. 2015 Oct.
Abstract
Importance: Understanding skin cancer incidence is critical for planning prevention and treatment strategies and allocating medical resources. However, owing to lack of national reporting and previously nonspecific diagnosis classification, accurate measurement of the US incidence of nonmelanoma skin cancer (NMSC) has been difficult.
Objective: To estimate the incidence of NMSC (keratinocyte carcinomas) in the US population in 2012 and the incidence of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) in the 2012 Medicare fee-for-service population.
Design, setting, and participants: This study analyzes US government administrative data including the Centers for Medicare & Medicaid Services Physicians Claims databases to calculate totals of skin cancer procedures performed for Medicare beneficiaries from 2006 through 2012 and related parameters. The population-based National Ambulatory Medical Care Survey database was used to estimate NMSC-related office visits for 2012. We combined these analyses to estimate totals of new skin cancer diagnoses and affected individuals in the overall US population.
Main outcomes and measures: Incidence of NMSC in the US population in 2012 and BCC and SCC in the 2012 Medicare fee-for-service population.
Results: The total number of procedures for skin cancer in the Medicare fee-for-service population increased by 13% from 2,048,517 in 2006 to 2,321,058 in 2012. The age-adjusted skin cancer procedure rate per 100,000 beneficiaries increased from 6075 in 2006 to 7320 in 2012. The number of procedures in Medicare beneficiaries specific for NMSC increased by 14% from 1,918,340 in 2006 to 2,191,100 in 2012. The number of persons with at least 1 procedure for NMSC increased by 14% (from 1,177,618 to 1,336,800) from 2006 through 2012. In the 2012 Medicare fee-for-service population, the age-adjusted procedure rate for BCC and SCC were 3280 and 3278 per 100,000 beneficiaries, respectively. The ratio of BCC to SCC treated in Medicare beneficiaries was 1.0. We estimate the total number of NMSCs in the US population in 2012 at 5,434,193 and the total number of persons in the United States treated for NMSC at 3,315,554.
Conclusions and relevance: This study is a thorough nationwide estimate of the incidence of NMSC and provides evidence of continued increases in numbers of skin cancer diagnoses and affected patients in the United States. This study also demonstrates equal incidence rates for BCC and SCC in the Medicare population.
Similar articles
- Incidence estimate of nonmelanoma skin cancer in the United States, 2006.
Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, Coldiron BM. Rogers HW, et al. Arch Dermatol. 2010 Mar;146(3):283-7. doi: 10.1001/archdermatol.2010.19. Arch Dermatol. 2010. PMID: 20231499 - Prevalence of a history of skin cancer in 2007: results of an incidence-based model.
Stern RS. Stern RS. Arch Dermatol. 2010 Mar;146(3):279-82. doi: 10.1001/archdermatol.2010.4. Arch Dermatol. 2010. PMID: 20231498 - Incidence of nonmelanoma skin cancer in New Brunswick, Canada, 1992 to 2001.
Hayes RC, Leonfellner S, Pilgrim W, Liu J, Keeling DN. Hayes RC, et al. J Cutan Med Surg. 2007 Mar-Apr;11(2):45-52. doi: 10.2310/7750.2007.00010. J Cutan Med Surg. 2007. PMID: 17374314 - Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review.
Barton V, Armeson K, Hampras S, Ferris LK, Visvanathan K, Rollison D, Alberg AJ. Barton V, et al. Arch Dermatol Res. 2017 May;309(4):243-251. doi: 10.1007/s00403-017-1724-5. Epub 2017 Mar 11. Arch Dermatol Res. 2017. PMID: 28285366 Free PMC article. Review. - Epidemiology of nonmelanoma skin cancer.
Strom SS, Yamamura Y. Strom SS, et al. Clin Plast Surg. 1997 Oct;24(4):627-36. Clin Plast Surg. 1997. PMID: 9342506 Review.
Cited by
- A recent update on the connection between dietary phytochemicals and skin cancer: emerging understanding of the molecular mechanism.
Singh H, Mishra AK, Mohanto S, Kumar A, Mishra A, Amin R, Darwin CR, Emran TB. Singh H, et al. Ann Med Surg (Lond). 2024 Aug 7;86(10):5877-5913. doi: 10.1097/MS9.0000000000002392. eCollection 2024 Oct. Ann Med Surg (Lond). 2024. PMID: 39359831 Free PMC article. Review. - Immunosuppression regimen and latitude impact keratinocyte carcinoma risk in U.S. liver transplant recipients.
Rosenthal BE, Schaubel DE, Lewis JD, Margolis DJ, Goldberg DS, Bittermann T. Rosenthal BE, et al. Arch Dermatol Res. 2024 Sep 26;316(9):641. doi: 10.1007/s00403-024-03404-3. Arch Dermatol Res. 2024. PMID: 39325226 Free PMC article. - Freedom from Recurrence across Age in Non-Melanoma Skin Cancer Treated with Image-Guided Superficial Radiation Therapy.
Farberg AS, Heysek RV, Haber R, Agha R, Crawford KM, Xinge J, Stricker JB. Farberg AS, et al. Geriatrics (Basel). 2024 Sep 5;9(5):114. doi: 10.3390/geriatrics9050114. Geriatrics (Basel). 2024. PMID: 39311239 Free PMC article. - Genetic Causal Relationship Between Sex Hormones and Basal Cell Carcinoma: A Two-Sample Mendelian Randomization Study.
Luo P, Gao D, Wang C, Guo R, Zhang Q. Luo P, et al. Clin Cosmet Investig Dermatol. 2024 Sep 14;17:2077-2088. doi: 10.2147/CCID.S479500. eCollection 2024. Clin Cosmet Investig Dermatol. 2024. PMID: 39296326 Free PMC article. - Cutaneous Squamous Cell Carcinoma in Patients with Solid-Organ-Transplant-Associated Immunosuppression.
Khaddour K, Murakami N, Ruiz ES, Silk AW. Khaddour K, et al. Cancers (Basel). 2024 Sep 4;16(17):3083. doi: 10.3390/cancers16173083. Cancers (Basel). 2024. PMID: 39272941 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials